Open and closed circles represent Group 3 (saline-treated) and Group 4 (ANPtreated) rats, respectively. Open and closed circles represent Group 3 and Group 4 rats, respectively. Table III summarizes the results of the histologic studies. The grade of necrosis in the proximal tubule was significantly lower in the ANP-treated rats (Group 4) than in the saline-treated rats (Group 3). The extent of cast formation in the outer medulla also tended to be less severe in Group 4, although this tendency was not statistically significant. Figure 2 illustrates the relationship between the severity of necrosis in the proximal tubule and BUN, and Fig. 3 the relationship between the extent of cast formation in the outer medulla and BUN. Moderately strong correlations existed in both cases (necrosis-BUN; rk=0.557, p<0.05, cast-BUN; rk=0.593, p<0.05).
DISCUSSION
The present study demonstrated a therapeutic effect of ANP during both acute renal dysfunction and the chronic course of glycerol-induced ARF.
In acute experiments, ANP induced a profound natriuresis in the ARF rats although the GFR increase by ANP was smaller than that in the control rats. In view of the small GFR response, this natriuresis may be due to either reduced tubular reabsorptive capacity (reflected by increased FENa) and/or direct tubular effects of ANP.13),14) These responses to ANP are consistent with the recent report by Heidbreder et al,15t which examined the acute effects of ANP in the less severe form of glycerol-induced ARF.
Several recent studies have shown that ANP can almost completely restore the GFR in the ischemic ARF model.6)-8) The reasons for the lack of GFR restoration in the present study are unknown. However, differences between ischemic and glycerol models16) may be responsible for this discrepancy. Detailed information about the altered renal microcirculation after the glycerol injection should help resolve this question.
The decreased RBF in the ARF rats is a common finding in the glycerol model2),17)-19) and filtration failure is generally attributed to cortical ischemia.17),18) In addition to plasma volume depletion, activation of the reninangiotensin system is thought to be involved in the fall of RBF.11),19)-21) Interestingly, the RBF responses to ANP were quite different between the control and ARF rats: a sustained RBF increase was observed only in the ARF group. The slight decrease in RBF in the control group cannot be attributed to hypotension because BP remained within the limits for renal autoregulation.12) In this regard, Camargo et al reported that ANP decreased the renal vascular resistance in the presence of norepinephrine, angiotensin II (All), or vasopressin, and increased the resistance in the absence of any vasoconstrictors.22) From these observations they concluded that ANP behaves as a functional agonist/antagonist of endogenous vasoconstrictors, which may explain the different patterns of RBF responses to ANP in the present study.
In chronic experiments, the 75-min ANP infusion after the glycerol injection significantly lessened the degree of both azotemia and renal histological injury. There are several possible mechanisms for these long-term protective effects of ANP.
First, the improvement of RBF during ANP infusion could partially protect the kidney from ischemic insult. However, a previous study showed that RBF improvement induced by the inhibition of AII did not improve the renal dysfunction in this model,21) suggesting that the beneficial effects of ANP cannot be completely explained by the improvement of RBF. Second, ANPinduced diuresis could prevent intratubular cast formation. Tubular obstruction by casts is not considered to be the most important factor for the reduced filtration in the early stage of the glycerol model.11),20),23) However, Cushner et al suggested that intratubular casts play some role in the maintenance stage of this model.24) The results of our histologic analysis seem to support this view. Similar to other reports,25),26) the degree of proximal necrosis and the extent of cast formation in the outer medullar correlated well with the degree of azotemia. Both the degree of necrosis and cast formation tended to be less severe with ANP treatment, but only the effect on necrosis was statistically significant. The demonstration of these correlations does not neces-sarily mean a causal relationship, but these results suggest that the long-term effect of ANP may in part come from the prevention of the cast formation. Finally, other actions of ANP could protect the kidney against glycerol-induced ARF. The direct tubular effects of ANP (such as influences on intracellular calcium concentrations) should be clarified in future studies.
In addition to different effects on GFR (discussed previously), there is a discrepancy in histological findings from ischemic and glycerol-induced AFR. Specifically, ANP did not lessen the renal histological injuries in the ischemic model despite more favorable responses in the acute phase.7) We cannot readily explain this discrepancy.
However, it is likely that the mechanisms of action of ANP are different in these different experimental models of ARF. In this regard, it is important to note that these models respond differently to other agents such as furosemide,1),2)
The results of the present study suggest that ANP may be useful in the treatment of human ARF. Although the protective effects of ANP have been documented previously in the ischemic ARF model,6)-9) the glycerol model is thought to better reproduce some types of human ARF.10)11) The clinical use of ANP in ARF is of considerable interest. However, the prevention of severe hypotension during ANP infusion will be critical. We needed to replenish large volume losses during the ANP-induced natriuresis to avoid systemic hypotension.
Given the unstable hemodynamic status of many ARF patients, the combined use of vasoactive agents such as dopamine with ANP may be worth considering in clinical trials, as suggested by Conger et al.9) In summary, ANP induced a profound natriuresis and improved both GFR and RBF in the early stages of the glycerol-induced ARF model. However, the improvement of GFR was smaller compared to the previous results in the ischemic model. An ANP infusion after a glycerol injection also lessened both the degree of azotemia and the extent of the renal histologic injuries. These results are more promising than the effects of furosemide previously reported in this model,1),2) suggesting that ANP may be useful in the treatment of ARF.
